nsv5340065
- Organism: Homo sapiens
- Study:nstd200 (Abel et al. 2020)
- Variant Type:translocation
- Method Type:Sequencing
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:1
- Publication(s):Abel et al. 2020
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 440 SVs from 49 studies. See in: genome view
Overlapping variant regions from other studies: 259 SVs from 49 studies. See in: genome view
Overlapping variant regions from other studies: 137 SVs from 40 studies. See in: genome view
Overlapping variant regions from other studies: 442 SVs from 49 studies. See in: genome view
Overlapping variant regions from other studies: 247 SVs from 53 studies. See in: genome view
Variant Region Placement Information
| Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop | strand |
|---|---|---|---|---|---|---|---|---|---|---|
| nsv5340065 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000007.14 | Chr7 | 152,282,692 | 152,282,692 | + |
| nsv5340065 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000021.9 | Chr21 | 10,445,414 | 10,445,414 | + |
| nsv5340065 | Remapped | Perfect | GRCh38.p12 | PATCHES | Second Pass | NW_011332699.1 | Chr13|NW_0 11332699.1 | 123,958 | 123,958 | + |
| nsv5340065 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000007.13 | Chr7 | 151,979,777 | 151,979,777 | + | ||
| nsv5340065 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000021.8 | Chr21 | 11,067,043 | 11,067,043 | + |
Variant Call Information
| Variant Call ID | Type | Method | Analysis |
|---|---|---|---|
| nssv16413446 | interchromosomal translocation | Sequencing | Sequence alignment |
Variant Call Placement Information
| Variant Call ID | Placement Type | Score | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop | strand |
|---|---|---|---|---|---|---|---|---|---|
| nssv16413446 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000007.14 | Chr7 | 152,282,692 | 152,282,692 | + |
| nssv16413446 | Remapped | Perfect | GRCh38.p12 | Second Pass | NW_011332699.1 | Chr13|NW_0 11332699.1 | 123,958 | 123,958 | + |
| nssv16413446 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000021.9 | Chr21 | 10,445,414 | 10,445,414 | + |
| nssv16413446 | Submitted genomic | GRCh37 (hg19) | NC_000007.13 | Chr7 | 151,979,777 | 151,979,777 | + | ||
| nssv16413446 | Submitted genomic | GRCh37 (hg19) | NC_000021.8 | Chr21 | 11,067,043 | 11,067,043 | + |
No validation data were submitted for this variant
No clinical assertion data were submitted for this variant
Genotype Information
| Variant Call ID | Allele Frequency (AF) | Allele Count (AC) | Allele Number (AN) |
|---|---|---|---|
| nssv16413446 | 0.501 | 8428 | 16834 |